SCHEMBL18178317

SCHEMBL18178317

CCOc1cccc(OC(=O)OC)c1COc1cc(Cl)c(C)cc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
MRGPRX4 Q96LA9 9/20 0.40
LMNA P02545 1/20 0.40
RXFP1 Q9HBX9 1/20 0.37
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
FABP4 P15090 1/20 0.35
FABP5 Q01469 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178414 0.92 KCNK3 (0.42) KCNK3KCNK9MRGPRX4RXFP1MEN1
SCHEMBL18178707 0.91 MRGPRX4 (0.41) KCNK3KCNK9MRGPRX4LMNARXFP1
SCHEMBL18178314 0.91 MRGPRX4 (0.42) MRGPRX4LMNAALDH1A1
SCHEMBL18178309 0.91 MRGPRX4 (0.42) MRGPRX4LMNAALDH1A1
SCHEMBL18182194 0.90 MRGPRX4 (0.44) KCNK3KCNK9MRGPRX4RXFP1POLB
SCHEMBL18178315 0.90 MRGPRX4 (0.44) KCNK3KCNK9MRGPRX4LMNAFABP4
SCHEMBL18178308 0.89 MRGPRX4 (0.41) MRGPRX4LMNA
SCHEMBL18178221 0.89 KCNK3 (0.40) KCNK3KCNK9MRGPRX4RXFP1POLB
SCHEMBL18178310 0.88 MRGPRX4 (0.40) MRGPRX4LMNAALDH1A1
SCHEMBL18178312 0.88 MRGPRX4 (0.40) MRGPRX4LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 KCNK3 463/4885KCNK9 626/4885MRGPRX4 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.